Healthcare [ 7/13 ] | Medical Instruments & Supplies [ 131/159 ]
NASDAQ | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 26, 23 | -2.92 Decreased by -279.22% | -2.85 Decreased by -2.46% |
| Jul 27, 23 | -0.59 Increased by +37.23% | -0.49 Decreased by -20.41% |
| May 10, 23 | -0.71 Increased by +69.53% | -0.49 Decreased by -44.9% |
| Mar 15, 23 | -0.7 Increased by +44.44% | -1.01 Increased by +30.69% |
| Nov 9, 22 | -0.77 Increased by +35.83% | -1.06 Increased by +27.36% |
| Aug 11, 22 | -0.94 Decreased by -17.5% | -1.09 Increased by +13.76% |
| May 10, 22 | -2.33 Decreased by -66.43% | -1.17 Decreased by -99.15% |
| Mar 22, 22 | -1.26 Increased by +10% | -1.26 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 1.82 M Decreased by -19.32% | -2.04 M Increased by +54.61% | Decreased by -112.27% Increased by +43.74% |
| Jun 30, 23 | 2.04 M Decreased by -4.27% | -4.18 M Increased by +10.56% | Decreased by -204.61% Increased by +6.57% |
| Mar 31, 23 | 1.89 M Increased by 0% | -4.64 M Increased by +16.94% | Decreased by -245.66% Increased by +16.94% |
| Dec 31, 22 | 2 M Decreased by -16.73% | -4.12 M Increased by +17.55% | Decreased by -205.85% Increased by +0.99% |
| Sep 30, 22 | 2.25 M Decreased by -4.82% | -4.49 M Increased by +8.51% | Decreased by -199.56% Increased by +3.88% |
| Jun 30, 22 | 2.13 M Decreased by -23.91% | -4.67 M Decreased by -90.42% | Decreased by -219% Decreased by -150.26% |
| Mar 31, 22 | 1.89 M Decreased by -26.22% | -5.58 M Decreased by -10.53% | Decreased by -295.76% Decreased by -49.81% |
| Dec 31, 21 | 2.4 M Decreased by -12.04% | -5 M Decreased by -7.9% | Decreased by -207.91% Decreased by -22.68% |
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.